Wednesday, December 2, 2020

Patient Journey: One Platform for Aggregation and Integration

Data Aggregation and Integration
Provide a complete view of the patient journey 
Ensure the commercial success of your Specialty therapies by leveraging de-identified detailed data about patients, their physicians, and healthcare organizations.

To build commercial success, nothing is more essential than accessing complete, consistent, and reliable patient journey analytics to quickly identify the obstacles that negatively affect the patient's access and outcome. Access is enabled by combining ValueCentric's expertise in data aggregation
with the option to seamlessly integrate additional IQVIA syndicated data. We provide a comprehensive view of the patient journey across all data assets on one platform. 
In the white paper, Hunting for Specialty Therapeutics Patients? Data Aggregators Can Help, you will learn 

  • How to create a valuable comprehensive view of the patient journey
  • Why data aggregation is key in the creation of the patient journey 
  • What to look for when vetting aggregators
The white paper was written by John Giannouris, Vice President of Specialty Data Strategy and Consulting Services for ValueCentric, an IQVIA company. Over the last 10+ years, John has spearheaded the formation and growth of ValueCentric's and IMS' (now IQVIA) Specialty Pharma Data Aggregation and Integration practices. He has directed the implementation of data aggregation projects for more than 80 specialty drugs, including more than 50 specialty drug launches. 

There is more!
View John's four-part Specialty Solutions blog series.
© 2020 IQVIA. All rights reserved.
Contact us at valuecentric.com
4820 Emperor Boulevard, Durham, NC 27703, USA
83 Wooster Heights Road, Danbury, CT 06810, USA

Want to reach 64,000+ biopharma industry executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of Industry Dive, Inc. 1575​ Eye St NW, Suite 400, Washington,​ DC 20005

No comments:

Post a Comment